High Tower Advisors, LLC Adma Biologics, Inc. Transaction History
High Tower Advisors, LLC
- $71.3 Billion
- Q1 2025
A detailed history of High Tower Advisors, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 30,208 shares of ADMA stock, worth $602,347. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,208
Previous 99,381
69.6%
Holding current value
$602,347
Previous $1.7 Million
64.85%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ADMA
# of Institutions
378Shares Held
188MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$372 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$336 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$257 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$228 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$113 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.92B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...